Glioma SOX2 expression decreased after adjuvant therapy

BACKGROUND: SOX2 is regarded as an important marker in stem cell. The change of SOX2 expression after adjuvant therapy in high grade glioma (HGG) remains unknown so far. Few patients with recurrent glioma have opportunity to undergo operation once again, so the recurrent glioma samples are scarce. T...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Wei, Ren, Xiaoqiu, Hu, Chunxiu, Tan, Yinuo, Shui, Yongjie, Chen, Zexin, Zhang, Lili, Peng, Jiaping, Wei, Qichun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6849258/
https://www.ncbi.nlm.nih.gov/pubmed/31718604
http://dx.doi.org/10.1186/s12885-019-6292-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6849258/
https://www.ncbi.nlm.nih.gov/pubmed/31718604
http://dx.doi.org/10.1186/s12885-019-6292-y

Ejemplares similares